ロード中...
Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
INTRODUCTION: Migraine is the most common neurological disorder and one of the major causes of years lived with disability. Its treatment (especially of chronic forms) is often challenging and accompanied with adverse effects. Although new therapeutic approaches have recently emerged (eg, calcitonin...
保存先:
| 出版年: | BMJ Open |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8230930/ https://ncbi.nlm.nih.gov/pubmed/34162645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-045969 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|